By Rosalie Bertell, GNSH, Ph.D.

Robert L. Egan is credited with the development of mammography equipment in 1960, 50 years ago. The first commercial machine was available in 1965. The requirements for an acceptable technology at that time were that the findings be reproducible, using the same instrument and technician. No health or safety studies were undertaken before it was promoted for general usage by the medical community. Nor was there concern about compression of the breast, known at the time to risk rupture of an already formed tumor, causing metastasis. The fact that X-ray exposure caused breast cancer was not widely known until the late 1970’s.

Mammography programs gradually spread geographically since that time, although some in the medical research community have been opposed to their widespread use for screening (not for diagnosis) from the beginning. The root cause of suspicion about the use of mammography has been that they expose the breast tissue to X-radiation, which to this date is the only proven cause of breast cancer. The counter argument has been that early detection of breast cancer prevents breast cancer death, therefore any breast cancers that are caused by the X-ray will be detected early and “cured”, if the woman stays in the program. Unfortunately both of these theories appear to be false, given the new understanding of the biophysical cause of most breast cancers (up to 95% of the total).

In this paper I will discuss new findings as to the underlying cause of breast cancer (and other cancers), and the new light that this shines on old “truths” about diagnosis and treatments. This new finding supposes an understanding of the sub-atomic structure of matter (quantum physics), an area where direct observation is impossible and one must use indirect methods for demonstrating that the new understanding is accurate. These indirect methods include the ability to diagnose breast cancer using the theory, and the ability to prescribe and predict treatment outcomes which are medically successful. This new theory has proven accurate so far in both of these aspects. Women will be glad to know that under this new understanding of breast cancer’s cause and treatment, neither the biochemical approach to a cure, using chemotherapy with its devastating side effects, nor radiation therapy, which can induce new cancers as well as cause cardiovascular diseases, are needed for detection or treatment of up to 95% of breast cancers. Although I need to talk about findings in biophysics, I will try to use familiar terms and understandable science.

Relevant Findings in Quantum Physics:

Most people have learned about the atomic structure, namely that the atom is composed of electrically negative electrons and an equal number of electrically positive protons. All atoms except hydrogen also contain neutrons, which are electrically neutral. All atoms by nature therefore, having equal positive and negative charges, are electrically neutral. Atoms combine to form molecules in accordance with the rules of chemistry, and together atoms and molecules make up all living and non-living material in our universe.

In 1915, Niels Bohr proposed a deeper structural model for the atom, based on the solar system. This similarity between the planetary model and the Bohr Model of the atom ultimately arises because the attractive gravitational force in a solar system and the attractive Coulomb (electrical) force between the positively charged nucleus and the negatively charged electrons in an atom are mathematically of the same form. It was observed that the electrons moved in “shells” with specific energy around the nucleus, and the energy existed in quanta, i.e. the electron could move between the adjoining shells by gaining or losing exactly one quanta of energy. This has led to the name Quantum Theory, or more specifically, Quantum Mechanics as the study of motion in this extremely small sub-atomic domain.

In 1962, at Stanford University in Menlo Park, California, a particle physics research center was established. Through bombarding of protons with electrons and examining the tracks of the sub-atomic particles released by this process, many different sub-atomic particles have been discovered. This research has established as factual that the proton and neutron contain smaller particles, called quarks, arranged in orderly fashion and in constant motion. The ‘new’ atom was found to consist mostly of empty space. The general size of an atom is 10-10 meter [imagine a meter stick, or yard stick, divided into ten billion parts], while the size of the nucleus of the atom is 10-15 to 10-14 meter [the nucleus of the atom is therefore 10,000 to 100,000 times smaller than the atom].

It is difficult to get a mental picture of the atom, but thinking about the solar system with planets both spinning on an axis and moving in their orbits around the sun, is a good start. The atom is mostly energy, with its “size” determined by the constant motion of the atomic and sub-atomic particles, just as a human can take up more space by spinning an object around him/her self so that no one can get close without an encounter with the moving object. Our solar system, although it contains much empty space, effectively defines an area in space in which it moves and that it consistently occupies in time.

Taking one step further into this subatomic realm, and imagining that within the electron itself, and the quarks, which make up protons and neutrons, there are even smaller particles, which we will call ‘gravity photons’, moving constantly with extremely small electric particle ‘field energy’, and you have grasped the newest picture of the atom. In summary, this new theory posits extremely small electrical particles, ‘gravity photons’: the electrical energy of which make up quarks (components of protons and neutrons) and electrons, and the electrical energy of which is constantly moving within a tightly defined space-time standing wave. These ‘gravity photons’ form the fundamental particles giving rise to the electrical energy of quarks, protons, neutrons and electrons, which in turn form atoms and molecules. This is a very new understanding of atoms, available to only a small number of scientists since about 1994, and its implications are not widely known or understood. Intact atoms are the smallest unit of all chemical and biochemical reactions, while the ‘gravity photon’ electrical particles form a digital bioelectric communication system, within or below the chemical system, important in maintaining healthy living tissue, organs and the whole intact living being.

How do we know this is a true picture of the atom?

We are relying first on the theoretical advances in understanding made by Robert Wood-Smith, with the collaboration of an independent scientist Albert Mantiziba B.Sc.(Hons.) Chemical Engineering, in 1994 and later as a Partner¹. These two scientists are responsible for developing the equations and quantification of this theory of electrical particle ‘gravity photons’ and harmonizing their findings with classical and quantum physics. They have also derived theories based on this new understanding which elucidate some of the most difficult-to-treat modern diseases, including cancer, and have paused in their work in physics to communicate these health-related findings to inform medical personnel, and enhance their power to heal.

In 1994, Robert Wood-Smith predicted that the electron was energized by extremely small partial electrical charges which he called quarkels (small quarks). The 1998 Nobel Prize in Physics was awarded to three scientists in the United States, for their discovery that the electron had components. This was confirmation of the existence, but not the nature of the quarkels.

The CERN Collider, Geneva, Switzerland, is a massive physics experiment in which protons are accelerated to very high speed and made to collide with one another, in the hopes of discovering their component parts. Hence belief that quarks and electrons are fundamental particles which cannot be divided is waning in the scientific community.

Science magazine in 1996 reported that American researchers have said, they found that collisions between quarks in a particle accelerator were unexpectedly violent. William Carithers, of Fermi National Accelerator Laboratory, in Batavia, Illinois, told Science — “This is just the sort of effect you would see if quarks were not fundamental particles, but had some sort of internal structure.”²

Chris Hill, theorist at Fermilab, indicated the view in New Scientist: “It would suggest that whatever lies inside the quarks is incredibly tightly bound, in a way that theory can’t yet accommodate.”³ On the 1st March 1997 — in an article in New Scientist,⁴ results from DESY, the German Electron Synchrotron pointed to the existence of what is described as a “leptoquark”, within the electron (previously called a quarkel by Robert Wood-Smith). Robin Marshall of the University of Manchester, who was involved in the work, said “The leptoquark is a bizarre object that we don’t understand completely”. Researchers said this “could mean that quarks and leptons (electrons) are not fundamental particles after all, but are made up of even smaller particles”

Nature of these sub-atomic electrical particles called ‘gravity photons’:

The ‘gravity photon’ is seen as a waveform. It needs to be understood, that the waveform (i.e. a wavelength) is a ‘profile’ indicating the pathway of an ‘electric particle’ (with a partial charge) consisting of gravitational energy. Researchers assumed that for electromagnetic photons the length of the wave form or ‘profile’ was the ‘size’ of the particle. Light is shed on the science of electromagnetic waves, by considering the report in Nature⁵ and within New Scientist⁶. A team led by Thomas Ebbesen of the Louis Pasteur University in Paris and the NEC Research Unit in Princeton, New Jersey, made their discovery quite by chance when they set out to make “quantum cavities” in a glass-backed metal film. In order to check the quality of the cavities, they illuminated them with a range of wavelengths.

Ebbesen stated —

“To our astonishment, we saw light transmitted with 100 per cent efficiency at a wavelength 10 times bigger than the diameter of the hole”.

Ebbesen, realizing ‘theory’ had suggested the photon has an effective size roughly equal to its wavelength (that is, it “made itself seem larger” by constant motion), commented “So it should not be able to squeeze through a smaller hole”. Unless, that is, the waveform (i.e. wavelength) is being formed by a small enough ‘particle of electric energy’ which would be able to —

1. Pass through a hole larger than its diameter; taking into account the angle of approach of the particle, and its relative position within the waveform at the precise moment the particle approached the ‘hole’.
2. The particle would then be able to continue to develop the profile of its waveform, on the other side of the glass-backed metal film — and did so.

The article in New Scientist concluded with the statement by Ebbesen, “However, we have shown we can get 1000-nanometre light through 150-nanometre holes”.

The former ‘theory’ that the photon has an effective size equal to its wavelength, no longer stands. A wavelength may now be understood to result from a ‘particle of energy’ (the fundamental photon) being displaced by its waveform over a distance in-time. The length of that displacement-in-time will determine the characteristic presented by the energy — a reality demonstrated by study of the various frequencies that comprise the photons of the electromagnetic spectrum. These variable characteristics are now used to form radio waves, microwaves, infrared, visible light, ultraviolet light and X-ray, gamma rays and cosmic photons, likely also electricity.

Modern Medicine is based largely on Biochemistry:

Mendeleev’s Principles of Chemistry, Russian 5th ed., which introduced the chemical chart, was first translated to English in 1891. Dmitri Mendeleev, a Russian chemist, had designed a Periodic Table similar to the one we use today, thus facilitating an understanding of the chemical basis of living beings. This made chemistry the most advanced of the sciences at the turn of the twentieth century. At the time, the bioelectric properties of the human body were recognized but their mechanisms were not understood, and many dubious electrical experimental treatments were being practiced by doctors, some bordering on quackery.

In 1910, the Flexner Report⁷ was issued to reform medical education in North America and at the same time, to bring it into the mainstream of scientific methodology. The Report demanded higher admission requirements and graduation standards for medical schools. University Medical education adopted the scientific method and was thoroughly grounded in human anatomy, physiology and biochemistry. Unfortunately, to curb the excesses in bogus electrical treatments, the Report banned the use of biophysical treatments “until there was a thorough understanding of the underlying science”. Subsequently, biophysics was dropped in most medical curricula, and the medical profession began to depend only on pharmaceuticals (chemicals) and vaccines (chemicals) to solve all medical problems. As was noted, chemicals work on the atomic and molecular level, but are ineffective when the sub-atomic level is abnormal. Looking back, we see that during the past century great strides in understanding the fundamentals of physics have been made, yet the medical community is ill prepared to understand, let alone use, this new knowledge.

Medicine has progressed greatly, but it is still unable to treat or treat successfully many antibiotic resistent infections, cancer, and various other illnesses like Alzheimers, Parkinson’s disease and AIDS which resist pharmaceutical treatment. Some cancers have been successfully treated with X-radiation, although this treatment also has unwanted side effects. As a class, these diseases exhibit non-or miss-communication properties, relative to the human body’s immune system (which fails to destroy them as “foreign”) and standard (normal) medicines (which fail to work as expected). The opposite is true of AIDS, in which a change in the body’s immune system makes it unable to recognize and mark for destruction pathogens which invade the body. It is these difficult or seemingly impossible to treat pathologies that can be expected to benefit most from a deeper understanding of the subatomic electrical particle theory.

The commonality in these diverse pathologies is the non- or miss-communication between the body’s immune system and normal medicines with the pathogen. In this context, the new understanding of the electrical particle ‘field energy’ generated by the ‘gravity photons’ within quarks and electrons of the atoms, is that the photon vibrations (moving within a standing wave) have slowed to a speed less than the speed of light c, that is, they are vibrating at less than the normal speed applying to the atoms of matter on this planet. Most people have experienced the non-or miss-communication or garbled message of a digital transmission which is played at a slower than normal speed. This is similar.

What could have caused the slowing down of the primordial motion of the ‘gravity photons’, within the quarks and electrons of atoms in previously healthy tissue? The only known particles on our earth which have electric particle ‘field energy’ at slower than the speed of light c, are radioactive particles — alpha, beta and gamma particles, violently exploded from the nucleus of unstable chemical elements like uranium, thorium or radium which occur naturally in bedrock and other naturally occurring unstable elements, or the unstable elements like cesium137, strontium90 and iodine131 which are artificially produced in a nuclear reactor or nuclear explosion. Energy is emitted whenever a nuclear transformation (i.e. transformation in the nucleus of an atom) takes place: lighter elements are formed, as particles are emitted from the nucleus, where they have previously been very tightly bound.. During this extraordinary process the Law of Conservation, over a period of time, slows down the electric particle ‘field energy’ of a samll proportion of the parent heavy unstable element’s energy, and this portion is then removed from the mass of the heavier element as a ‘radioactive particle’. Alpha, beta and/or gamma particles are released in the process of nuclear transformation. These radioactive particles having been physically (measureably) slowed down in ejection velocity relative to their mass: the alpha particle is a helium atom minus its electrons, and it is slowed down the most, then the beta particle which is an electron, and then the gamma (photon) which is slow by the least amount.

The slower moving electrical energy of these radioactive particles can come into direct contact or close vicinity of atoms in DNA within cells of living tissues: this applies also to proteins, bacteria, and viruses, in plants, animals or humans. One sequella, is that the affected DNA can begin to propogate electrically abnormal pathogenic cells. The normal vibrations, within some of the tissue’s cellular atoms, can begin to move in-sync with the abnormal vibration of the electric particle ‘field energy’ within atoms of the ‘abnormal DNA’- some whole cells becoming ‘abnomal cells’, that is, out-of-sync within the natural tissue environment. One such series of changed cells is referred to as a cancer.

This problem is made worse by the various chemical hazards in the environment, which can destroy the natural immunity to background radiation in the environment, especially of the DNA within cells.⁹. Once a sufficient number of cells become ‘abnormal’, this abnormal slower moving ‘field energy’ forms characteristic abnormalities associated with the various electrical energy related pathologies (called ‘radiosensitive’, since they respond to energy treatment by electricle particle ‘field energy’ at the speed of light c). This phenomenon has been recently called genomic instability. It appears to be involved also in the mysterious ‘bystander effect’ by which cells not directly affected by radiation, but near to the affected cells, can also develop malignancies or other pathologies.

Implications for Breast Cancer:

One of the most difficult medical problems facing doctors today is the growing toxicity of chemotherapy needed to overcome the disease cancer. It is demanding the most toxic of pharmaceutical medicines and the most extreme of radiation therapies and even with this all-out assault on the breast tissue, the breast cancer is often fatal. Understanding of the abnormally slow ‘field energy’ of this pathology (in up to 95% of cases, as observed in Europe and North America) leads to remedies which raise the energy level of the radiosensitive tissue, so that the message of the electrically abnormal (radiosensitive) cancerous tissue can be ‘read’ by the body’s immune system and thereby marked for destruction by the immune system. Normal tissue, already operating with ‘field energy’ at the speed of light c, will not be affected by this therapy.

Diagnosis:

In an American clinical trial involving 463 women (100 of whom were known to have breast cancer) the Biofield Diagnostic System scanner, which records the low electric particle ‘field energy’ characteristics of tissue, was able to select and identify 95% of women with known breast cancer as having slower than normal ‘field energy’, i.e. as being radiosensitive. In this test two metal discs are placed on the breast and the electrical differential between the two is measured. There is no compression of the breast needed. This clinical trial confirmed that most breast cancers in the United States trial were formed of electric particle ‘field energy’ which was moving slower than normal ‘field energy’ of the speed of light c. The only known cause of such an abnormal state would require any of three states:

• Loss of normal protection of the DNA against natural background radiation, since radioactive particles are the only particles on earth known to have an abnormally slow electric particle ‘field energy’,
• Exposure to such abnormal background radiation either from a natural source, a technologically enhanced natural sources (like uranium mining debris) or fission/activation products from nuclear reaction activities,
• And the ability for tissue in close contact with an abnormal radioactive particle to harmonize its electric particle ‘field energy’ with that of the radioactive particle.

It is scientifically feasible that the loading of toxic chemicals now in our environment has undermined the natural ability of the body to resist the background radiation hazard. This natural resistance ability, perhaps due to greater opportunity for absorption of toxic chemicals, may also decline with chronological age, since, historically, most cancers have occurred in old age.

These slow electric particle ‘field energy’ breast cancers (up to 95% of the total in the United States trial referred to above) are precisely the breast cancers caused by exposure to radioactive particles (alpha, beta or gamma particles) known to have slower electric particle ‘field energy’ than the speed of light c. The 5% or more of the breast cancers which do not exhibit a slower then normal electric particle ‘field energy’, are the result of ionization or genetic inheritance, and will require different treatment than is discussed in this paper.

The Biofield Diagnostic System scanner¹⁰ is designed to replace the mammography machines. It is more efficient in recognizing radiosensitive cancers than are mammography, ultra sound or physical examination¹¹. It is also able to diagnose about 30% of those breast cancers in younger women with dense breasts, which are usually missed by mammography.

The Biofield Diagnostic System scanner can successfully distinguish between those breast cancers which will respond to electric particle energy treatment (commonly up to 95%, less in some countries), with photoelectric or low intensity microwave treatment, and those which require different treatment (commonly 5% or more). It does not require compression of the breast, and does not itself cause breast cancer.

Biofield Corp., with headquarters in King of Prussia, PA, and the MacKay Group recently established a Chinese national healthcare joint venture built around Biofield’s breast cancer diagnostic device. MacKay has been backing Biofield since 2004. The Joint Venture (JV) will be called Worldwide Lifecare Limited or the Carelife JV because the agreement is between Biofield and Carelife, which is operating through its appointed agent, China International Exchange Ltd. Funded with approximately $363 million, the Carelife JV have opened a China network of medical clinics, call centers and data centers for R&D. The first medical clinic opened in October 2008 at Carelife’s China Headquarters in Shanghai. By 2012, Carelife expects to open more than 500 medical clinics in China’s major cities, which will make the JV’s technology available to a 60% share of China’s urban population. The JV includes, as a partner, China’s National Labor Union and it is funded with an investment by the Chinese Government. The 500 medical centers will open in Labor Union centers. China’s major insurance carriers have agreed to refer their clients to the centers.

On 12 June 2003, a similar instrument, the Trimprob was introduced at the San Carlo Borromeo Hospital and the European Institute of Oncology, both in Milan, Italy¹². The Trimprobe is able to detect a variation in electromagnetic wavelengths between healthy tissue and cancerous tissues. Breast cancers formed by slower than normal electric particle ‘field energy’ resonates around 400 megahertz; while healthy (normal for particle electric ‘field energy’) breast tissue resonates at 1350 megahertz. Therefore, Trimprobe is capable of identifying up to 95% of radiosensitive breast cancers. The Trimprob analyzes the condition of tissues and organs in real time, detects and localizes radiosensitive pathologies ranging from inflammatory conditions to cancers and, most importantly, finds them at a very early stage. It can be used while patients are dressed and comfortable, and offers immediate results with a high degree of effectiveness.

Trimprob contains an antenna that generates an electromagnetic field at very low power, much less than that of a cell-phone, interacting with tissues at the submicroscopic level. A computer linked to the probe analyzes the amount of interference at different frequencies and displays results in real time in an easily understandable graphical format.

The Biofield Diagnostic System scanner and the Trimprob are consistent with the theory put forth by Robert Wood-Smith and explained here. Additionally, they help to confirm this new understanding of the deeper subatomic problem underlying most cancers, including breast cancer.

Treatment:

The tumors that are characterized by slower moving electric particle ‘field energy’ within the atoms of diseased tissues, will respond to high or low frequency electrical particle ‘field energy’ at the speed of light c. This accounts, for example, for the observation that X-ray therapy has been widely recognized as able to treat cancer. However, the mechanism by which the radiotherapy success occurred has not been well understood. Furthermore, the use of high frequency electric particle ‘field energy’ can cause ionization and do severe damage to near-by healthy tissue: this reality has long been recognized by the medical profession and by patients. By using lower frequency electric particle ‘field energy’ at the speed of light c, which will not damage healthy tissue by ionization, much of this collateral damage can be avoided.

The new understanding of the mechanism which underlies the success of the proposed alternative treatment — is that an appropriate input of electric particle ‘field energy’ at the speed of light c, can cause the ‘field energy’ in the radiosensitive tumor to be brought up gradually to that of normal tissues. Care is, of course, taken to avoid heating of the tissue to a point of killing the healthy cells, or prolonging treatment so as to cause any other electromagnetic damage to normal tissue.

When the electrical particle ‘field energy’ of the cancerous tissue has been normalized in ‘field energy’, the “message” carried by the DNA of the tumor can be understood by the body’s immune system and the cells can ‘communicate’ with other pharmaceutical treatments or be marked as pathogenic for destruction by the immune system. This is not a matter of “killing” the cancer cells either by heat or high frequency energy damage.

Examples of Treating Cancer Successfully

Seven years ago, Dr. David Lloyd, consultant liver surgeon at the Leicester Royal Infirmary, and clinical tutor in surgery at the University of Leicester Medical School, in the U.K., came up with the idea of placing a tiny probe into liver tumors to irradiate them with microwaves. To date, more then 100 patients diagnosed with inoperable liver cancer (terminal cancer) have been treated with the technique and in 95% of these patients, the cancer disappeared. The best results are in those patients receiving some chemotherapy as well to help reduce the chance of cancer re-occurring elsewhere, but patients’ life expectancies increased dramatically, already in some cases by several years.

One of these patients was Maureen Horney, from Sussex. She said:
“When I was first diagnosed with liver cancer I contacted the Mayo Clinic in America for advice and doctors told me my tumors were untreatable. They gave me a maximum of six months to live. I then found out about Dr. Lloyd’s unique microwave probe and I am now alive and well — four years after being diagnosed with inoperable cancer.”

Dr Lloyd said:

“Thousands of patients die each year from the effects of liver cancer either because the disease is unresectable [cannot be removed surgically] or it does not respond to chemotherapy.

“The microwave machine which has been developed at University Hospital Leicester can treat very large tumors within a few minutes. I have now treated nearly 100 patients and over 200 cancers. The microwave device is extremely safe, very effective and easy to use and is proving to be a significant advance in the treatment of liver cancer.”

The microwave treatment has attracted attention from experts worldwide, so much so that Dr Lloyd has been asked to talk about the ground-breaking treatment at a number of international meetings. Dr Lloyd has addressed the Prime Minister of Malaysia, where liver cancer is endemic, the American Congress of Surgeons, the European Hepatbobiliary Association and the World Congress of Liver Surgery meeting in Las Vegas, USA, in September 2007.

This same method could be used for breast cancer in cases where the tumors are sufficient in size for insertion of a small metal probe. Most recently, the Oklahoma University Cancer Institute in the USA has introduced ‘focused microwave thermotherapy’ for the treatment of breast cancer — which is said to reduce the number of women needing a breast removed, by up to 90 per cent. It is said, “This research is in the early stages.” I would assume since they use the word “thermo” that the researchers think they are seeing a thermal effect, which in due course is likely to be viewed as a mistake. However understanding of the vibrational effect of microwave on subatomic particles is a very new concept, which may not yet have become available for study by these researchers.

The Indiba MD-308, is another instrument being used for low energy ‘electric field’ treatment for tissue with slower than normal electric particle ‘energy field’. It is a non-invasive instrument utilizing 200 watts over 50 ohms, at 500 kHz. Indiba medical equipment has been used extensively by Dr. Adolfo Ley-Valle, Barcelona, and it has a respected safety record.

Light itself can be used to treat successfully radiosensitive cancers (that is, those cancers with slower than normal electric particle ‘field energy’) on the surface of the skin, or within the lungs — where in either case there is easy access to apply the treatment known as Photodynamic Therapy (PDT). After sensitizing the skin cancer to light, followed by irradiation with a suitable wavelength of laser light, which is comprised, of course, with particle electric ‘field energy’ at the speed of light c — the slower moving electric particle ‘field energy’ of the atoms of cells forming the cancer, becomes elevated in ‘field energy’ speed towards the ‘normal’ electric particle ‘field energy’ speed of light c.

Dr. Jeremy George of University College London Hospital, has utilized Photodynamic Therapy to treat lung cancer with success. A camera is inserted into the lungs of the cancer patient together with a blue light suitable for detecting tumors. Normal lung tissue will reflect back the bluish light. However, because the electric particle ‘field energy’ of radiosensitive tumors is energized with a slower than normal ‘field energy’ speed — the blue light is absorbed and radiated back at a slower electric particle ‘field energy’ speed. The slower electric particle ‘field energy’ speed has the effect of inducing a slightly lower wavelength — i.e. within the red/mauve spectrum of visible light. In this way the tumors become easily identifiable to the doctor treating the patient. In specific published case notes — the patient concerned was treated for 45 minutes and was able to return home the next day. The patient has remained clear of lung cancer since his treatment.

Dr. Jeremy George has indicated PDT has a significant potential.

“Other consultants have used it very successfully on a variety of cancers, but photodynamic therapy will not take off universally without support from the Departments of Health and organizations like the Medical Research Council or the National Academy of Science.”

Blue laser light is also being used during cancer surgery to check the edges of removed tissue to see whether or not all cancerous tissue has been removed.

When the electric particle ‘field energy’ of the ‘base pair’ atoms comprising the DNA of the cancer cell has been elevated to the normal ‘field energy’ speed of the electromagnetic spectrum — the body is able to:

• decode the information associated with the cell —
• recognize the cancer cell as foreign and —
• mark the cell, to be destroyed by the immune system.

Summary:

The new designation, ‘radiosensitive cancers’, has been given to those cancers which can be treated successfully with an appropriate application of electric particle ‘field energy’ at the speed of light c. These cancers reflect a condition, where the electric particle ‘field energy’ of a substantial number of atoms comprising the cells of the tumor, operate at a speed which is slower moving than the ‘normal’ speed of light c. The latter normal speed is the ‘field energy’ speed shared by all of the frequencies of the electromagnetic spectrum, i.e. the speed of light c. Those cancers which are not radiosensitive, are being called radioresistant. They have normal electric particle ‘field energy’, and are formed through ionization or genetic inheritance. Their electrical particle ‘field energy’ is that of the speed of light c.

The Future:

Obviously this brief glimpse at a new understanding of the subatomic abnormality of most breast cancers, their diagnosis and treatment, based on a new understanding of subatomic physics, cannot answer all questions which the reader might have! There will be many more useful insights developed, clarifying the genesis and treatment of other cancers and diseases which resist today’s medical treatment modalities.

I have also not fully dealt in this paper with treatment of the 5% or more of radioresistent breast cancers which will not respond to this new treatment. However this topic will require a new paper.

What is most needed now is openness on the part of the Medical Regulators and clinical physicians to allow for guided experimentation with this most promising medical breakthrough. Robert Wood-Smith stands ready to help those who wish such guidance, asking only for his out-of-pocket expenses. It should make sense to have a knowledgeable physicist, who has discovered this mechanism, guide the experiments to utilize this knowledge for its healing potential. Double blind clinical trials need to be launched and women need to be helped to realize that breast cancer need not be the scourge which burdens families with years of suffering, and cuts short women’s lives.

There are also implications for the nuclear commercial and weapon industries which could not be sufficiently fleshed out here. Radiation Protection Standards, set on the assumption that the only radiation related cancers were those due to ionization will need to be updated to account for the inordinate effect of internal contamination with unstable atoms which emit particles with slower electric particle ‘field energy’ than that of normal living cells. This subatomic vibrational effect of radioactive alpha, beta and gamma particles was not foreseen by those who set the radiation standards in 1950¹⁴!

Future research will need to apply this new understanding to radioactive particle affects to proteins, bacteria and viruses, and to intra and intercellular communication in higher organisms, including animals and humans. This new understanding will require profound examination of long accepted radiation protection policies, especially for internal exposures, which are now known to be non-protective of living things.

While new avenues of healing are opened up, old counterproductive policies must be changed: both changes will bring about significant changes in the lives of ordinary people. We can expect these changes to take place at different rates geographically and in time, but they give hope of a much healthier future for the living beings on planet Earth!

References and Notes:

¹ “Medical Science is in Crisis Worldwide”, by Robert Wood-Smith, Robert Wood-Smith & Partners, (2002) Authoritative Advisors in Radiation and Genomic Instability. Copy available on request.

² Science February 1996.

³ New Scientist, 11th May 1996; page 29.

⁴ New Scientist, 1st March 1997, page 14

⁵ Nature, vol. 391, p 667, 1998.

⁶ New Scientist 14th February 1998

⁷ Medical Education in the United States and Canada, by Abraham Flexner, 1910.

⁸ Researchers at the Max Planck Institute of Physics in Munich, Germany, in 2009 added to our knowledge of the difference in speed gamma photons have, compared with electric particle energy of photons of the electromagnetic spectrum , i.e. the speed of light c — a difference so minuscule, it has needed the latest equipment to measure the almost imperceptible slower speed concerned. However, even this difference, so difficult for human technology to measure, is able to disrupt the delicate communication system formed by the human tissue’s electrical particle ‘field energy’.

⁹ There are about three billion base pair in the human DNA, which carry the genetic information and triggers. Some are affected by interaction with toxic chemicals endemic in our environment which singly or in combinations expose DNA to low-level radioactivity within the natural environment.

¹⁰ The Biofield Diagnostic System has been developed and tested by the world’s leading breast cancer specialists. It has been developed to make mammograms and all other current breast cancer diagnostic technologies obsolete in the next generation. Biofield Corp., currently partnering with MacKay Life Sciences, is located in King of Prussia, PA. [King of Prussia Business Center, Suite C, 1019 West Ninth Ave., King of Prussia, PA, United States.]

¹¹ Physical examination of the breast has 71–80% sensitivity and 20% to 40% specificity; Ultrasound has 60–80% sensitivity and 34–74% specificity; Diagnostic Mammography has 78–90% sensitivity and 20–40% specificity; Biofield has 90–95% sensitivity and 40–65% specificity. Only Biofield Diagnostic System and Trimprob provide objective information on breast cancer.

¹² On 21 July 2003 — Trimprob, Tissue Resonance Interaction Method, a hand-held, portable, quick, non invasive cancer detection tool was introduced in the United States at a Washington D.C. press conference. Similar to a metal detector used to frisk airline passengers, Trimprob is a light weight (1.3 pounds) plastic baton that produces a beam of microwaves. It is based on patented technology discovered in Italy by physicist Clarbruno Vedruccio and developed by a defense company Galileo Avionica, a subsidiary of Finmeccanica S.p.A., Italy’s largest defense and aerospace group with annual revenues of approximately $8.5 billion.

¹³ University of Leicester website — Liver Cancer Microwave Treatment.

¹⁴ “The organization of Protective Measures Against Radiation Hazards”, by M.V. Mayneord, in Biological Hazards of Atomic Energy, Ed. A. Haddow, Oxford in Clarendon Press, 1952.